CHEK2 and cancer: So far, the c.1100delC and p.I157T CHEK2 variants are the most comprehensively studied, being associated in large case–control studies with increased risk for different types of cancer, such as testicular germ cell tumours, breast and colorectal cancers [22,23,24].